← Back to all trials
Recruiting
NCT07417111
Continued Pressure for Alveolar Protection (CPAP Trial)
Conditions: Bronchopulmonary Dysplasia (BPD)
Sex: All
Ages: N/A – 31 Weeks
Healthy volunteers: No
Phase: NA
Enrollment: 860
Sponsor: NICHD Neonatal Research Network
Location: University of Alabama at Birmingham Birmingham Alabama
Summary
The objective of the CPAP Trial is to test whether extending CPAP until 34 weeks' PMA or for at least 2 additional weeks compared to weaning to a nasal canula will decrease the likelihood of bronchopulmonary dysplasia or death at 36 weeks' PMA.
Eligibility Criteria
Inclusion Criteria:
* Gestational age \
Source: ClinicalTrials.gov (NCT07417111). StuddyBuddy aggregates publicly available trial information.
